Browsing by Author Myers, S

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
1-Nov-2018Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic ModalitiesEapen, MS; Hansbro, PM; Larsson‑Callerfelt, AK; Jolly, MK; Myers, S; Sharma, P; Jones, B; Rahman, MA; Markos, J; Chia, C; Larby, J; Haug, G; Hardikar, A; Weber, HC; Mabeza, G; Cavalheri, V; Khor, YH; McDonald, CF; Sohal, SS
1-Jan-2019Epithelial–mesenchymal transition is driven by transcriptional and post transcriptional modulations in copd: Implications for disease progression and new therapeuticsEapen, MS; Sharma, P; Gaikwad, AV; Lu, W; Myers, S; Hansbro, PM; Sohal, SS
1-Feb-2019Heparin-binding epidermal growth factor (HB-EGF) drives EMT in patients with COPD: implications for disease pathogenesis and novel therapiesEapen, MS; Sharma, P; Thompson, IE; Lu, W; Myers, S; Hansbro, PM; Sohal, SS
31-Jul-2019New therapeutic targets for the prevention of infectious acute exacerbations of COPD: Role of epithelial adhesion molecules and inflammatory pathwaysAtto, B; Eapen, MS; Sharma, P; Frey, U; Ammit, AJ; Markos, J; Chia, C; Larby, J; Haug, G; Weber, HC; Mabeza, G; Tristram, S; Myers, S; Geraghty, DP; Flanagan, KL; Hansbro, PM; Sohal, SS
3-Oct-2018sE-cadherin and sVE-cadherin indicate active epithelial/endothelial to mesenchymal transition (EMT and EndoMT) in smokers and COPD: implications for new biomarkers and therapeuticsEapen, MS; Myers, S; Lu, W; Tanghe, C; Sharma, P; Sohal, SS